236 related articles for article (PubMed ID: 38037144)
1. Transformation of non-neuritic into neuritic plaques during AD progression drives cortical spread of tau pathology via regenerative failure.
Tsering W; Hery GP; Phillips JL; Lolo K; Bathe T; Villareal JA; Ruan IY; Prokop S
Acta Neuropathol Commun; 2023 Dec; 11(1):190. PubMed ID: 38037144
[TBL] [Abstract][Full Text] [Related]
2. Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation.
He Z; Guo JL; McBride JD; Narasimhan S; Kim H; Changolkar L; Zhang B; Gathagan RJ; Yue C; Dengler C; Stieber A; Nitla M; Coulter DA; Abel T; Brunden KR; Trojanowski JQ; Lee VM
Nat Med; 2018 Jan; 24(1):29-38. PubMed ID: 29200205
[TBL] [Abstract][Full Text] [Related]
3. Neuropathology of Alzheimer's Disease.
Trejo-Lopez JA; Yachnis AT; Prokop S
Neurotherapeutics; 2022 Jan; 19(1):173-185. PubMed ID: 34729690
[TBL] [Abstract][Full Text] [Related]
4. Pathological changes induced by Alzheimer's brain inoculation in amyloid-beta plaque-bearing mice.
Lam S; Hérard AS; Boluda S; Petit F; Eddarkaoui S; Cambon K; ; Picq JL; Buée L; Duyckaerts C; Haïk S; Dhenain M
Acta Neuropathol Commun; 2022 Aug; 10(1):112. PubMed ID: 35974399
[TBL] [Abstract][Full Text] [Related]
5. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
He SR; Liu DG; Wang S; Xia YJ
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
[TBL] [Abstract][Full Text] [Related]
6. Neuritic Plaques - Gateways to Understanding Alzheimer's Disease.
Tsering W; Prokop S
Mol Neurobiol; 2024 May; 61(5):2808-2821. PubMed ID: 37940777
[TBL] [Abstract][Full Text] [Related]
7. Progression of Alzheimer-related neuritic plaque pathology in the entorhinal region, perirhinal cortex and hippocampal formation.
Yilmazer-Hanke DM; Hanke J
Dement Geriatr Cogn Disord; 1999; 10(2):70-6. PubMed ID: 10026378
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology.
Serrano-Pozo A; William CM; Ferrer I; Uro-Coste E; Delisle MB; Maurage CA; Hock C; Nitsch RM; Masliah E; Growdon JH; Frosch MP; Hyman BT
Brain; 2010 May; 133(Pt 5):1312-27. PubMed ID: 20360050
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease.
Mizukami K; Akatsu H; Abrahamson EE; Mi Z; Ikonomovic MD
Neuropathology; 2016 Apr; 36(2):135-45. PubMed ID: 26293308
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease pathology in the neocortex and hippocampus of the western lowland gorilla (Gorilla gorilla gorilla).
Perez SE; Raghanti MA; Hof PR; Kramer L; Ikonomovic MD; Lacor PN; Erwin JM; Sherwood CC; Mufson EJ
J Comp Neurol; 2013 Dec; 521(18):4318-38. PubMed ID: 23881733
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of tau species and the association with cognitive decline and synaptic loss in Alzheimer's disease.
Saroja SR; Sharma A; Hof PR; Pereira AC
Alzheimers Dement; 2022 Sep; 18(9):1602-1615. PubMed ID: 34873815
[TBL] [Abstract][Full Text] [Related]
12. Reduced Reelin expression accelerates amyloid-beta plaque formation and tau pathology in transgenic Alzheimer's disease mice.
Kocherhans S; Madhusudan A; Doehner J; Breu KS; Nitsch RM; Fritschy JM; Knuesel I
J Neurosci; 2010 Jul; 30(27):9228-40. PubMed ID: 20610758
[TBL] [Abstract][Full Text] [Related]
13. Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology.
Laversenne V; Nazeeruddin S; Källstig EC; Colin P; Voize C; Schneider BL
Acta Neuropathol Commun; 2020 Nov; 8(1):198. PubMed ID: 33225991
[TBL] [Abstract][Full Text] [Related]
14. Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice.
Chen Y; Zhao S; Fan Z; Li Z; Zhu Y; Shen T; Li K; Yan Y; Tian J; Liu Z; Zhang B
Alzheimers Res Ther; 2021 Feb; 13(1):40. PubMed ID: 33563332
[TBL] [Abstract][Full Text] [Related]
15. Combinatorial model of amyloid β and tau reveals synergy between amyloid deposits and tangle formation.
Koller EJ; Ibanez KR; Vo Q; McFarland KN; Gonzalez De La Cruz E; Zobel L; Williams T; Xu G; Ryu D; Patel P; Giasson BI; Prokop S; Chakrabarty P
Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12779. PubMed ID: 34825397
[TBL] [Abstract][Full Text] [Related]
16. Clustering of tau-immunoreactive pathology in chronic traumatic encephalopathy.
Armstrong RA; McKee AC; Alvarez VE; Cairns NJ
J Neural Transm (Vienna); 2017 Feb; 124(2):185-192. PubMed ID: 27770214
[TBL] [Abstract][Full Text] [Related]
17. Aged chimpanzees exhibit pathologic hallmarks of Alzheimer's disease.
Edler MK; Sherwood CC; Meindl RS; Hopkins WD; Ely JJ; Erwin JM; Mufson EJ; Hof PR; Raghanti MA
Neurobiol Aging; 2017 Nov; 59():107-120. PubMed ID: 28888720
[TBL] [Abstract][Full Text] [Related]
18. Viewpoint: Crosstalks between neurofibrillary tangles and amyloid plaque formation.
Luan K; Rosales JL; Lee KY
Ageing Res Rev; 2013 Jan; 12(1):174-81. PubMed ID: 22728532
[TBL] [Abstract][Full Text] [Related]
19. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
[TBL] [Abstract][Full Text] [Related]
20. Pathology of clinical and preclinical Alzheimer's disease.
Thal DR; von Arnim C; Griffin WS; Yamaguchi H; Mrak RE; Attems J; Upadhaya AR
Eur Arch Psychiatry Clin Neurosci; 2013 Nov; 263 Suppl 2():S137-45. PubMed ID: 24077890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]